S. Vukelja
Impact in
Papers in
- Co-authors
- Joyce O’Shaughnessy (9 shared papers)Stephen E. Jones (3 shared papers)Frankie A. Holmes (3 shared papers)John A. Glaspy (1 shared paper)Bertrand C. Liang (1 shared paper)J. Shogan (1 shared paper)Luís Meza (1 shared paper)Lister Hill (1 shared paper)
- Journals
- Journal of Clinical Oncology (14 papers)Cancer Research (4 papers)Clinical Breast Cancer (2 papers)Molecular Therapy (1 paper)Breast Cancer Research and Treatment (1 paper)
- Partner nations
- United StatesItalyIndia
In The Last Decade
S. Vukelja
30 papers receiving 883 citations
Peers
Comparison fields: 5 of 72
- Oncology 707
- Genetics 370
- Dermatology 106
- Hematology 109
- Clinical Biochemistry 51
Countries citing papers authored by S. Vukelja
This map shows the geographic impact of S. Vukelja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Vukelja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Vukelja more than expected).
Fields of papers citing papers by S. Vukelja
This network shows the impact of papers produced by S. Vukelja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Vukelja. The network helps show where S. Vukelja may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Vukelja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2002 | 434 | |
| 2 | 2004 | 166 | |
| 3 | 2011 | 81 | |
| 4 | 2004 | 73 | |
| 5 | 1997 | 20 | |
| 6 | 2009 | 20 | |
| 7 | 2007 | 11 | |
| 8 | 2005 | 11 | |
| 9 | Lymphomatoid Papulosis Associated with Ki-1-Positive Anaplastic Large Cell Lymphoma. | 1994 | 10 |
| 10 | 2011 | 9 | |
| 11 | 2009 | 8 | |
| 12 | 2005 | 8 | |
| 13 | 2017 | 7 | |
| 14 | 1995 | 7 | |
| 15 | 2010 | 7 | |
| 16 | Xeloda (capecitabine) plus docetaxel combination therapy in locally advanced/metastatic breast cancer: Latest results | 2001 | 6 |
| 17 | 1990 | 6 | |
| 18 | 2001 | 5 | |
| 19 | 1992 | 4 | |
| 20 | 2007 | 4 |
About S. Vukelja
S. Vukelja is a scholar working on Oncology, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Genetics, having authored 30 papers that have together received 911 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (11 papers), HER2/EGFR in Cancer Research (6 papers), Colorectal Cancer Treatments and Studies (5 papers), Breast Cancer Treatment Studies (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Advanced Breast Cancer Therapies (3 papers), Estrogen and related hormone effects (3 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). The work is most often cited by research in Oncology (707 citations), Genetics (370 citations), Dermatology (106 citations), Hematology (109 citations) and Clinical Biochemistry (51 citations). S. Vukelja has collaborated with scholars based in United States, Italy and India. Frequent co-authors include Joyce O’Shaughnessy, Stephen E. Jones, Frankie A. Holmes, John A. Glaspy, Bertrand C. Liang, J. Shogan, Luís Meza, Lister Hill, Theresa Neumann and Israel Wiznitzer. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Clinical Breast Cancer, Molecular Therapy and Breast Cancer Research and Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.